US2010233291A1PendingUtilityA1

Animal lesion treatment and prevention formulations and methods

57
Assignee: SMITHYMAN DENNISPriority: Mar 12, 2009Filed: Oct 16, 2009Published: Sep 16, 2010
Est. expiryMar 12, 2029(~2.7 yrs left)· nominal 20-yr term from priority
A61K 9/0014A01N 59/00A01N 59/02A61K 33/34A01L 15/00A61K 45/06A61K 33/06A61K 33/38A61K 9/1611A61K 33/30A01N 59/16
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An illustrative embodiment of an animal lesion treatment and prevention formulation includes a quantity of water, at least one acid provided in the quantity of water and magnesium sulfate as acid/base buffer mixed in the quantity of water with the at least one acid. In some embodiments, an antimicrobial agent comprising at least one antimicrobial metal salt may be provided in the quantity of water with the at least one acid and the magnesium sulfate.

Claims

exact text as granted — not AI-modified
1 . A formulation, comprising:
 a quantity of water;   at least one acid provided in said quantity of water; and   magnesium sulfate as acid/base buffer mixed in said quantity of water with said at least one acid.   
     
     
         2 . The formulation of  claim 1  further comprising an antimicrobial agent comprising at least one antimicrobial metal salt provided in said quantity of water with said at least one acid and said magnesium sulfate. 
     
     
         3 . The formulation of  claim 2  wherein said quantity of water, said at least one acid and said magnesium sulfate comprises a formulation concentrate and further comprising a volume of water mixed with said formulation concentrate and said antimicrobial agent to form a formulation solution. 
     
     
         4 . The formulation of  claim 3  wherein said formulation solution comprises a footbath solution. 
     
     
         5 . The formulation of  claim 3  wherein said formulation solution has an initial pH of from about 1.3 to about 2.5. 
     
     
         6 . The formulation of  claim 3  wherein said formulation solution comprises a topical formulation solution. 
     
     
         7 . The formulation of  claim 3  wherein said formulation solution comprises a surface sanitation formulation solution. 
     
     
         8 . The formulation of  claim 2  wherein said at least one antimicrobial metal salt is an antimicrobial metal salt selected from the group consisting of copper, zinc, silver or any combination thereof. 
     
     
         9 . An animal lesion treatment and prevention formulation, comprising:
 a formulation solution comprising:
 a supply of water; 
 a formulation concentrate having at least one acid comprising at least one of sulfuric acid, a sulfuric acid derivative and sodium bisulfate, and magnesium sulfate as acid/base buffer and a quantity of water mixed in said supply of water; and 
 an antimicrobial agent comprising at least one antimicrobial metal salt mixed in said supply of water with said formulation concentrate. 
   
     
     
         10 . The formulation of  claim 9  wherein said supply of water comprises a supply of footbath water and said formulation solution comprises a formulation footbath solution. 
     
     
         11 . The formulation of  claim 10  wherein said formulation footbath solution has a pH of from about 1.3 to about 2.5, said magnesium sulfate is present in said formulation concentrate in a concentration of from about 9% to about 11% by weight and said at least one antimicrobial metal salt is present in said formulation footbath solution in a concentration of from about 0.1 lbs. to about 0.6 lbs. of said antimicrobial metal salt per gallon of said footbath water. 
     
     
         12 . The formulation of  claim 9  wherein said formulation solution comprises a topical formulation solution. 
     
     
         13 . The formulation of  claim 12  wherein said topical formulation solution has a pH of from about 1.0 to about 6.0, said magnesium sulfate is present in said formulation concentrate in a concentration of from about 1% to about 25% by weight and said at least one antimicrobial metal salt is present in said topical formulation solution in a concentration of from about 0.1 lbs. to about 0.6 lbs. of said antimicrobial metal salt per gallon of said supply of water. 
     
     
         14 . The formulation of  claim 9  wherein said formulation solution comprises a sanitation formulation solution. 
     
     
         15 . The formulation of  claim 14  wherein said sanitation formulation solution has a pH of from about 1.0 to about 6.0, said magnesium sulfate is present in said formulation concentrate in a concentration of from about 1% to about 25% by weight and said at least one antimicrobial metal salt is present in said sanitation formulation solution in a concentration of from about 0.1 lbs. to about 0.5 lbs. of said antimicrobial metal salt per gallon of said supply of water. 
     
     
         16 . An animal lesion treatment and prevention method, comprising:
 providing an aqueous formulation solution comprising at least one acid and magnesium sulfate as an acid/base buffer;   providing an animal having at least one lesion; and   treating said at least one lesion with said formulation solution.   
     
     
         17 . The method of  claim 16  further comprising providing an antimicrobial agent comprising at least one antimicrobial metal salt in said aqueous formulation solution. 
     
     
         18 . The method of  claim 17  wherein said providing an aqueous formulation solution comprises providing a formulation concentrate having a quantity of water and at least one acid comprising at least one of sulfuric acid, a sulfuric acid derivative and sodium bisulfate and magnesium sulfate as acid/base buffer mixed in said quantity of water; providing a supply of water; and mixing said formulation concentrate and said antimicrobial agent in said supply of water. 
     
     
         19 . The method of  claim 18  wherein said providing a supply of water comprises providing a supply of footbath water and said providing an aqueous formulation solution comprises providing a footbath solution by mixing said formulation concentrate and said antimicrobial agent in said supply of footbath water, and wherein said treating said at least one lesion with said formulation solution comprises immersing said at least one lesion in said footbath solution. 
     
     
         20 . The method of  claim 19  wherein said providing an aqueous footbath solution comprises providing a formulation footbath solution having a pH of from about 1.3 to about 2.5 and wherein said magnesium sulfate is present in said formulation concentrate in a concentration of from about 9% to about 11% by weight and said at least one antimicrobial metal salt is present in said formulation footbath solution in a concentration of from about 0.1 lbs. to about 0.6 lbs. of said antimicrobial metal salt per gallon of said footbath water. 
     
     
         21 . The method of  claim 16  wherein said providing an aqueous formulation solution comprises providing a topical formulation solution by mixing said formulation concentrate and said antimicrobial agent in said supply of water. 
     
     
         22 . The method of  claim 21  wherein said providing a topical formulation solution comprises providing a topical formulation solution having a pH of from about 1.0 to about 6.0 and wherein said magnesium sulfate is present in said formulation concentrate in a concentration of from about 1% to about 25% by weight and said at least one antimicrobial metal salt is present in said topical formulation solution in a concentration of from about 0.1 lbs. to about 0.6 lbs. of said antimicrobial metal salt per gallon of said supply of water. 
     
     
         23 . The method of  claim 21  further comprising forming a final topical formulation by subjecting said topical formulation solution to additional processing steps and wherein said treating said at least one lesion with said formulation solution comprises treating said at least one lesion with said final topical formulation. 
     
     
         24 . An surface sanitation treatment method, comprising:
 providing an aqueous formulation solution comprising at least one acid and magnesium sulfate as an acid/base buffer;   providing at least one surface; and   applying said formulation solution to said at least one surface.   
     
     
         25 . The method of  claim 24  further comprising providing an antimicrobial agent comprising at least one antimicrobial metal salt in said aqueous formulation solution. 
     
     
         26 . The method of  claim 25  wherein said providing an aqueous formulation solution comprises providing a formulation concentrate having a quantity of water and at least one acid comprising at least one of sulfuric acid, a sulfuric acid derivative and sodium bisulfate and magnesium sulfate as acid/base buffer mixed in said quantity of water; providing a supply of water; and mixing said formulation concentrate and said antimicrobial agent in said supply of water. 
     
     
         27 . The method of  claim 26  wherein said providing an aqueous formulation solution comprises providing a surface sanitation formulation solution by mixing said formulation concentrate and said antimicrobial agent in said supply of water. 
     
     
         28 . The method of  claim 27  wherein said providing a surface sanitation formulation solution comprises providing a surface sanitation formulation solution having a pH of from about 1.0 to about 6.0 and wherein said magnesium sulfate is present in said formulation concentrate in a concentration of from about 1% to about 25% by weight and said at least one antimicrobial metal salt is present in said topical formulation solution in a concentration of from about 0.1 lbs. to about 0.6 lbs. of said antimicrobial metal salt per gallon of said supply of water. 
     
     
         29 . The method of  claim 27  further comprising forming a final surface sanitation formulation by subjecting said surface sanitation formulation solution to additional processing steps and wherein said treating said at least one surface with said formulation solution comprises treating said at least one surface with said final surface sanitation formulation. 
     
     
         30 . The method of  claim 24  wherein said providing at least one surface comprises providing soft tissue and said applying said formulation solution to said at least one surface comprises applying said formulation solution to said soft tissue. 
     
     
         31 . The method of  claim 24  wherein said providing at least one surface comprises providing a hard surface and said applying said formulation solution to said at least one surface comprises applying said formulation solution to said hard surface. 
     
     
         32 . A formulation mix, comprising:
 a selected quantity of zinc sulfate monohydrate and a selected quantity of magnesium sulfate heptahydrate mixed with said zinc sulfate monohydrate.   
     
     
         33 . The formulation mix of  claim 32  further comprising an acid mixed with said zinc sulfate monohydrate and said magnesium sulfate heptahydrate. 
     
     
         34 . The formulation mix of  claim 33  wherein said acid comprises sodium bisulfate. 
     
     
         35 . The formulation mix of  claim 32  further comprising a flow aid mixed with said zinc sulfate monohydrate and said magnesium sulfate heptahydrate. 
     
     
         36 . The formulation mix of  claim 35  wherein said flow aid comprises zeolite. 
     
     
         37 . The formulation mix of  claim 32  further comprising a selected quantity of copper sulfate pentahydrate mixed with said zinc sulfate monohydrate and said magnesium sulfate heptahydrate. 
     
     
         38 . The formulation mix of  claim 32  wherein said zinc sulfate monohydrate is present in a quantity of from about 50% to about 90% by weight and said magnesium sulfate heptahydrate is present in a quantity of from about 5% to about 40% by weight. 
     
     
         39 . The formulation mix of  claim 38  further comprising sodium bisulfate in a quantity of from about 1% to about 5% by weight and zeolite in a quantity of from about 0.5% to about 2% by weight. 
     
     
         40 . The formulation mix of  claim 32  further comprising copper sulfate pentahydrate in a quantity of from about 20% to about 70% by weight and wherein said zinc sulfate monohydrate is present in a quantity of from about 10% to about 50% by weight and said magnesium sulfate heptahydrate is present in a quantity of from about 5% to about 40% by weight. 
     
     
         41 . The formulation mix of  claim 40  further comprising sodium bisulfate in a quantity of from about 1% to about 5% by weight and zeolite in a quantity of from about 0.5% to about 2% by weight. 
     
     
         42 . An animal lesion treatment and prevention formulation, comprising:
 a formulation solution comprising:
 a supply of water; 
 an acid/base buffer provided in said supply of water; and 
 a formulation mix provided in said supply of water with said acid/base buffer and comprising a selected quantity of zinc sulfate monohydrate and a selected quantity of magnesium sulfate heptahydrate mixed with said zinc sulfate monohydrate. 
   
     
     
         43 . The formulation of  claim 42  further comprising at least one of an acid and a flow aid provided in said supply of water. 
     
     
         44 . The formulation of  claim 43  wherein said acid comprises at least one of sodium bisulfate and sulfamic acid and said flow aid comprises zeolite. 
     
     
         45 . The formulation of  claim 42  further comprising a selected quantity of copper sulfate pentahydrate provided in said supply of water. 
     
     
         46 . An animal lesion treatment and prevention method, comprising:
 providing an aqueous formulation solution comprising an acid/base buffer and a formulation mix comprising a selected quantity of zinc sulfate monohydrate and a selected quantity of magnesium sulfate heptahydrate mixed with said zinc sulfate monohydrate;   providing an animal having at least one lesion; and   treating said at least one lesion with said formulation solution.   
     
     
         47 . The method of  claim 46  wherein said providing a formulation mix comprising a selected quantity of zinc sulfate monohydrate and a selected quantity of magnesium sulfate heptahydrate mixed with said zinc sulfate monohydrate comprises providing a formulation mix comprising a selected quantity of zinc sulfate monohydrate and a selected quantity of magnesium sulfate heptahydrate and at least one of an acid and a flow aid mixed with said zinc sulfate monohydrate. 
     
     
         48 . The method of  claim 46  wherein said providing a formulation mix comprising a selected quantity of zinc sulfate monohydrate and a selected quantity of magnesium sulfate heptahydrate mixed with said zinc sulfate monohydrate comprises providing a formulation mix comprising a selected quantity of copper sulfate pentahydrate mixed with said zinc sulfate monohydrate and said magnesium sulfate heptahydrate.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.